How is the Effectiveness of LMWH Monitored in Neonates?
Monitoring the effectiveness of LMWH in neonates involves measuring anti-Xa levels, which reflect the drug’s activity. Routine monitoring is crucial to ensure that the levels remain within the therapeutic range. Additionally, clinical assessments for signs of bleeding or thrombosis are necessary to evaluate the treatment’s overall effectiveness and safety.
